![Karim Lalji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Karim F.
Lalji is Director at Medicenna Therapeutics Corp.
since 2024.
Mr. Lalji is Chief Business Officer at ME Therapeutics Holdings, Inc. since 2024.
Former roles include Chairman & Chief Executive Officer at Microbion Corp., Director-Business Strategy at Merck & Co., Inc., Director at MSI Methylation Sciences, Inc., Director-Overseers Board at Beth Israel Deaconess Medical Center, Inc., Director at The Centre for Drug Research & Development, Director at Accel-Rx, Vice President-New Products Planning at Sumitomo Pharma America, Inc., and Chief Commercial Officer at Correvio Pharma Corp.
from 2006 to 2015.
Education includes graduate studies at Harvard University and undergraduate studies at Simon Fraser University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 25/09/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Direttore/Membro del Consiglio | 15/08/2024 |
| ME THERAPEUTICS HOLDINGS INC. | Corporate Officer/Principal | 25/10/2024 |
| Società | Posizione | Fine |
|---|---|---|
| CORREVIO PHARMA CORP. | Corporate Officer/Principal | 16/02/2015 |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Discovers, research and develops therapeutic products | Direttore/Membro del Consiglio | - |
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage pharmaceutical company | Amministratore Delegato | - |
Accel-Rx
 Accel-Rx Financial ConglomeratesFinance Provides investment services | Direttore/Membro del Consiglio | - |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for commercializing cardiovascular hospital drugs | Health Technology |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage pharmaceutical company | Health Technology |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products through compound leverage | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Discovers, research and develops therapeutic products | Commercial Services |
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Provides investment services | Finance |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
ME Therapeutics Holdings, Inc.
 ME Therapeutics Holdings, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
